NEJM lifts brain artery stenting study embargo early after Pittsburgh Post-Gazette break
Because of a story that appeared in the Pittsburgh Post-Gazette this morning, we are lifting the embargo immediately for the Original Article, “Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis,” and editorial, “The Challenges of Intracranial Revascularization for Stroke Prevention.” This article and editorial will be published on NEJM.org as soon as possible.
All other material on the NEJM Media Center is still subject to today’s 5 PM EDT embargo.
I’ve asked NEJM whether they plan to impose sanctions, and will update with anything I hear back.
Update, 3:50 p.m. Eastern, 9/7/11: There will be sanctions, says NEJM. This message will go out to its press list shortly:
On Wednesday morning, we lifted the embargo for the SAMMPRIS study and its related editorial due to an embargo break by the Pittsburgh Post-Gazette. While the Post-Gazette article was not written by a member of our embargoed access list, we feel there should be repercussions. We realize this breach was an inconvenience to those who have agreed to respect our embargo. As such, the Pittsburgh Post-Gazette will be suspended from our embargoed access list for six months.
The New England Journal of Medicine takes our press embargo seriously. We maintain it to create a level playing field for journalists, and to give them time to thoroughly and accurately prepare stories on often-complex material. We value your role in conveying the information we publish to a wider audience, and appreciate your regular adherence to the terms of our embargo.